Literature DB >> 18155531

Increased risk of hip fracture among men with CKD.

Annemarie C Dooley1, Noel S Weiss, Bryan Kestenbaum.   

Abstract

BACKGROUND: Patients with chronic kidney disease (CKD) have disturbances in mineral metabolism. Those requiring dialysis therapy are at substantially increased risk of fracture. However, fracture risk in patients with CKD not requiring dialysis has not been well studied. STUDY
DESIGN: Retrospective cohort. SETTING & PARTICIPANTS: We identified men who sought care at 8 Veterans Affairs Medical Centers located in the Northwest from July 1999 to March 2006 who had a glomerular filtration rate (GFR) less than 60 mL/min/1.73 m(2). Patients who received long-term dialysis therapy or had a previous organ transplant, diagnosis of cancer, or history of hip fracture were excluded. Proportional hazards models were used to estimate the association of GFR stage with relative risk of hip fracture. PREDICTOR: GFR estimated on the basis of 2 or more consecutively abnormal outpatient serum creatinine measurements during a 6-month period. OUTCOME: Hip fracture ascertained from patient medical records.
RESULTS: In 33,091 veterans, 176 hip fractures were identified. After adjustment for age, body mass index, diabetes, and use of selected medications, relative risks of hip fracture for men with a GFR of 30 to 59 and 15 to 29 mL/min/1.73 m(2) were 1.28 (95% confidence interval, 0.88 to 1.66) and 3.98 (95% confidence interval, 2.25 to 7.74), respectively. LIMITATIONS: Retrospective study of men only.
CONCLUSIONS: These results suggest that the risk of hip fracture in men with CKD stage 4 is increased to a degree similar to that of dialysis patients.

Entities:  

Mesh:

Year:  2008        PMID: 18155531     DOI: 10.1053/j.ajkd.2007.08.019

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  46 in total

Review 1.  Current status of bicarbonate in CKD.

Authors:  Mirela Dobre; Mahboob Rahman; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2014-08-22       Impact factor: 10.121

2.  Competing Risks of Fracture and Death in Older Adults with Chronic Kidney Disease.

Authors:  Rasheeda K Hall; Richard Sloane; Carl Pieper; Courtney Van Houtven; Joanne LaFleur; Robert Adler; Cathleen Colón-Emeric
Journal:  J Am Geriatr Soc       Date:  2018-01-10       Impact factor: 5.562

3.  Proteinuria Is Associated With Increased Risk of Fragility Fracture in Men With or at Risk of HIV Infection.

Authors:  Anda Gonciulea; Ruibin Wang; Keri N Althoff; Michelle M Estrella; Deborah E Sellmeyer; Frank J Palella; Jordan E Lake; Lawrence A Kingsley; Todd T Brown
Journal:  J Acquir Immune Defic Syndr       Date:  2019-07-01       Impact factor: 3.731

4.  Fracture risk in CKD.

Authors:  Kristine E Ensrud
Journal:  Clin J Am Soc Nephrol       Date:  2013-07-11       Impact factor: 8.237

5.  Cortical bone analysis in a predialysis population: a comparison with a dialysis population.

Authors:  Catarina Carvalho; J Magalhães; R Neto; L Pereira; P Branco; T Adragão; J M Frazão
Journal:  J Bone Miner Metab       Date:  2016-11-09       Impact factor: 2.626

Review 6.  Bone Quality in Chronic Kidney Disease: Definitions and Diagnostics.

Authors:  Erin M B McNerny; Thomas L Nickolas
Journal:  Curr Osteoporos Rep       Date:  2017-06       Impact factor: 5.096

7.  The clinical utility of FRAX to discriminate fracture status in men and women with chronic kidney disease.

Authors:  S A Jamal; S L West; T L Nickolas
Journal:  Osteoporos Int       Date:  2013-10-11       Impact factor: 4.507

8.  The Likelihood of Self-reporting Balance Problems in Those With Advanced Chronic Kidney Disease, Slow Gait Speed, or Low Vitamin D.

Authors:  Jordan F Wickstrom; Harlan R Sayles; Laura A Graeff-Armas; Jennifer M Yentes
Journal:  J Ren Nutr       Date:  2018-12-21       Impact factor: 3.655

9.  Young patients and those with a low eGFR benefitted more from denosumab therapy in femoral neck bone mineral density.

Authors:  Ben-Chung Cheng; Ying-Chou Chen
Journal:  Clin Rheumatol       Date:  2016-10-18       Impact factor: 2.980

10.  Skeletal effects of zoledronic acid in an animal model of chronic kidney disease.

Authors:  M R Allen; N X Chen; V H Gattone; X Chen; A J Carr; P LeBlanc; D Brown; S M Moe
Journal:  Osteoporos Int       Date:  2012-08-21       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.